丙氨酸转运受损或D-环丝氨酸暴露增加MRSA对β-内酰胺类抗生素的敏感性
本研究报道cycA基因失活可使耐甲氧西林金黄色葡萄球菌(MRSA)对β-内酰胺类抗生素重新敏感,cycA突变导致对D-环丝氨酸(DCS)高度敏感并损害丙氨酸转运。cycA突变或DCS暴露均与缺乏末端d-ala-d-ala的三肽茎壁肽积累及肽聚糖交联减少相关,DCS在体外使MRSA对β-内酰胺类重新敏感,并在小鼠菌血症模型中显著增强奥西林对MRSA的清除。
要点
- cycA失活使MRSA对β-内酰胺类抗生素重新敏感。
- DCS在体外和小鼠菌血症模型中增强β-内酰胺类的杀菌效果。
- 丙氨酸转运可作为增强MRSA对β-内酰胺类敏感性的新靶点。
核心结论
- 丙氨酸转运受损或DCS暴露可增加MRSA对β-内酰胺类抗生素的敏感性。
- 丙氨酸转运是增强MRSA对β-内酰胺类敏感性的新治疗靶点。
研究设计与样本
- 研究使用MRSA的cycA突变体,并在小鼠菌血症模型中评估DCS与奥西林的联合效果。
主要发现
- cycA突变导致MRSA对β-内酰胺类抗生素重新敏感,并对DCS高度敏感。
- cycA突变体中丙氨酸转运受损,与对奥西林和DCS的敏感性增加相关。
- cycA突变或DCS暴露均与缺乏末端d-ala-d-ala的三肽茎壁肽积累及肽聚糖交联减少相关。
- DCS在体外使MRSA对β-内酰胺类重新敏感,并在小鼠菌血症模型中显著增强奥西林对MRSA的清除。
临床怎么用
- DCS或丙氨酸转运抑制可能作为联合策略增强β-内酰胺类对MRSA的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prolonging the clinical effectiveness of β-lactams, which remain first-line antibiotics for many infections, is an important part of efforts to address antimicrobial resistance. We report here that inactivation of the predicted d-cycloserine (DCS) transporter gene cycA resensitized methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. The cycA mutation also resulted in hypersusceptibility to DCS, an alanine analogue antibiotic that inhibits alanine racemase and d-alanine ligase required for d-alanine incorporation into cell wall peptidoglycan. Alanine transport was impaired in the cycA mutant, and this correlated with increased susceptibility to oxacillin and DCS. The cycA mutation or exposure to DCS were both associated with the accumulation of muropeptides with tripeptide stems lacking the terminal d-ala-d-ala and reduced peptidoglycan cross-linking, prompting us to investigate synergism between β-lactams and DCS. DCS resensitized MRSA to β-lactams in vitro and significantly enhanced MRSA eradication by oxacillin in a mouse bacteremia model. These findings reveal alanine transport as a new therapeutic target to enhance the susceptibility of MRSA to β-lactam antibiotics.
引用
- Gallagher LA, Shears RK, Fingleton C, et al. Impaired Alanine Transport or Exposure to d-Cycloserine Increases the Susceptibility of MRSA to β-lactam Antibiotics. J Infect Dis. 2020. PMID: 31628459. doi:10.1093/infdis/jiz542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。